Rise in Viral Infections Drives Growth in the Oral Antiviral Market: 2021-2031 Forecast
September 21, 2023 06:59 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com announces a comprehensive analysis of the Oral Antiviral Market, projecting a promising CAGR of 2.1% from 2022 to 2031. The "Oral...
Global Antimicrobial Ingredients Market is Expected to Reach USD 10.72 Billion by 2025 : Fior Markets
September 30, 2019 09:38 ET
|
Fior Markets
New Jersey, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The importance of antimicrobial ingredients in extending the shelf life of cosmetic products is a key factor driving the growth and adoption of...
OnCore Biopharma Licenses Second-Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection
September 09, 2014 03:00 ET
|
OnCore Biopharma, Inc.
OnCore Secures Exclusive Worldwide Rights to NVP018
NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV
DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...